NovoCure (NVCR) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for NovoCure (NVCR) over the last 12 years, with Q3 2025 value amounting to $112.0 million.
- NovoCure's Shares Outstanding rose 358.89% to $112.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $112.0 million, marking a year-over-year increase of 358.89%. This contributed to the annual value of $108.5 million for FY2024, which is 134.58% up from last year.
- According to the latest figures from Q3 2025, NovoCure's Shares Outstanding is $112.0 million, which was up 358.89% from $111.8 million recorded in Q2 2025.
- NovoCure's 5-year Shares Outstanding high stood at $112.0 million for Q3 2025, and its period low was $103.2 million during Q1 2021.
- For the 5-year period, NovoCure's Shares Outstanding averaged around $106.7 million, with its median value being $106.6 million (2023).
- In the last 5 years, NovoCure's Shares Outstanding soared by 103.7% in 2022 and then surged by 360.47% in 2025.
- Over the past 5 years, NovoCure's Shares Outstanding (Quarter) stood at $104.0 million in 2021, then rose by 1.04% to $105.0 million in 2022, then grew by 1.93% to $107.1 million in 2023, then increased by 1.35% to $108.5 million in 2024, then grew by 3.19% to $112.0 million in 2025.
- Its last three reported values are $112.0 million in Q3 2025, $111.8 million for Q2 2025, and $111.5 million during Q1 2025.